+ND Capital

+ND Capital

Signal active

Investment Firm

Overview

+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.

Highlights

Founded

2002

Industry

Financial Services

Employees

11-50

Investment

58

Lead Investment

20

Exits

12

Stages

Early Stage Venture, Late Stage Venture, Private Equity, Seed

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

+ND Capital, established in 2002 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity, Seed investments across Biotechnology, Pharmaceutical, Biopharma, Venture Capital, Finance, Business Development, Health Care, Financial Services, Advice, Semiconductor. The organization boasts a portfolio of 57 investments, with an average round size of $36.4M and 12 successful exits. Their recent investments include Selecta Biosciences, Flagship Pioneering, Polaris Partners, Crocus Technology, Idinvest Partners. The highest investment round they participated in was $201.2B. Among their most notable exits are Selecta Biosciences and Flagship Pioneering. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Jonathan Nicholson

Jonathan Nicholson

Director

imagePlace Richard Coles

Richard Coles

Director

imagePlace Eric Moessinger

Eric Moessinger

Partner

imagePlace Kirill Kuzmichev

Kirill Kuzmichev

Principal

imagePlace Colin Walsh

Colin Walsh

Vice President

imagePlace Ed Baetge

Ed Baetge

Venture Partner

Investment portfolio

+ND Capital has made 58 investments. Their most recent investment was on Jul 31, 2024, when AIRNA raised $60.0M.

+ND Capital has made 9 diversity investments. Their most recent diversity investment was on Oct 20, 2016, when Emulate raised $17.0M.

investments

58

Diversity investments

9

Lead investments

20

Number of exits

12

Investments

58

Annouced DateOrganization NameIndustryMoney Raised
Sep 26, 2023
Partillion Bioscience Partillion Bioscience
Biotechnology5.0M
Dec 14, 2023
Vandria Vandria
Pharmaceutical20.8M
Feb 28, 2024
PulseSight Therapeutics PulseSight Therapeutics
Biotechnologynull
Jul 31, 2024
AIRNA AIRNA
Biotechnology60.0M

Exits

12

Funding Timeline

Funding rounds

58

Investors

0

Funds

2

Funding Rounds

58

+ND Capital has raised 58 rounds. Their latest funding was raised on Jul 31, 2024 from a Series A - AIRNA round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Sep 26, 2023
Seed Round - Partillion Bioscience Seed Round - Partillion Bioscience
-5.0M-
Dec 14, 2023
Series A - Vandria Series A - Vandria
-20.8M-
Feb 28, 2024
Seed Round - PulseSight Therapeutics Seed Round - PulseSight Therapeutics
-0-
Jul 31, 2024
Series A - AIRNA Series A - AIRNA
-60.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.